IRIS
SANTORO, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.778
NA - Nord America 17.208
AS - Asia 10.620
SA - Sud America 4.107
AF - Africa 311
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 16
Totale 54.062
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.763
RU - Federazione Russa 10.242
SG - Singapore 4.425
BR - Brasile 3.491
IT - Italia 3.340
CN - Cina 2.805
IE - Irlanda 2.299
SE - Svezia 1.929
HK - Hong Kong 1.095
DE - Germania 920
VN - Vietnam 724
FR - Francia 662
UA - Ucraina 508
FI - Finlandia 471
NL - Olanda 405
IN - India 398
GB - Regno Unito 357
BD - Bangladesh 255
AR - Argentina 230
CA - Canada 213
PL - Polonia 202
MX - Messico 131
TR - Turchia 121
IQ - Iraq 100
EC - Ecuador 98
JP - Giappone 93
ZA - Sudafrica 91
ID - Indonesia 83
CO - Colombia 72
AT - Austria 68
ES - Italia 66
UZ - Uzbekistan 65
PK - Pakistan 64
VE - Venezuela 63
BE - Belgio 59
MA - Marocco 52
CZ - Repubblica Ceca 44
CL - Cile 42
PY - Paraguay 41
AE - Emirati Arabi Uniti 31
AZ - Azerbaigian 31
KE - Kenya 30
PE - Perù 30
IL - Israele 28
PH - Filippine 28
RO - Romania 28
SA - Arabia Saudita 28
EG - Egitto 26
MY - Malesia 26
NP - Nepal 26
CI - Costa d'Avorio 25
JO - Giordania 25
TN - Tunisia 25
UY - Uruguay 25
JM - Giamaica 23
AL - Albania 22
CH - Svizzera 22
DZ - Algeria 22
GR - Grecia 20
LT - Lituania 20
KZ - Kazakistan 19
DO - Repubblica Dominicana 18
KG - Kirghizistan 17
IR - Iran 15
AU - Australia 14
BO - Bolivia 14
CR - Costa Rica 14
LB - Libano 14
BG - Bulgaria 12
GE - Georgia 11
OM - Oman 11
PS - Palestinian Territory 11
ET - Etiopia 10
EU - Europa 10
RS - Serbia 10
KR - Corea 9
GT - Guatemala 8
LV - Lettonia 8
NO - Norvegia 8
AM - Armenia 7
BY - Bielorussia 7
CY - Cipro 7
HN - Honduras 7
NI - Nicaragua 7
NZ - Nuova Zelanda 7
PA - Panama 7
PT - Portogallo 7
SN - Senegal 7
SY - Repubblica araba siriana 7
BH - Bahrain 6
EE - Estonia 6
MD - Moldavia 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
BN - Brunei Darussalam 5
HU - Ungheria 5
LK - Sri Lanka 5
TJ - Tagikistan 5
XK - ???statistics.table.value.countryCode.XK??? 5
Totale 53.991
Salva come PNG Salva come JPEG
Città #
Moscow 3.118
Ashburn 2.741
Dublin 2.293
Singapore 2.221
Dallas 2.109
Chandler 1.581
Jacksonville 1.100
Hong Kong 1.086
Beijing 992
Nyköping 959
San Jose 758
The Dalles 566
Princeton 425
Los Angeles 404
Medford 392
Lauterbourg 387
Messina 376
Cambridge 359
Dearborn 354
Des Moines 322
São Paulo 288
New York 286
Oude Meer 280
Boardman 253
Ann Arbor 242
Ho Chi Minh City 227
Buffalo 220
Munich 219
Rome 204
Warsaw 177
Milan 175
Hanoi 162
Hyderabad 148
Tianjin 131
Council Bluffs 124
San Mateo 120
Frankfurt am Main 114
Redondo Beach 114
Rio de Janeiro 105
Jinan 102
Woodbridge 102
Belo Horizonte 101
Guangzhou 100
Houston 94
Santa Clara 94
Wilmington 94
Orem 90
Tokyo 81
Turku 75
Bremen 73
Brooklyn 66
Shenyang 66
Catania 64
Seattle 64
Brasília 62
Montreal 62
Palermo 62
Denver 59
Tashkent 58
Nanjing 56
Nuremberg 56
Shanghai 56
Brussels 55
Curitiba 55
Chennai 52
Pune 52
Johannesburg 49
Stockholm 48
Ottawa 47
Porto Alegre 46
Turin 45
Helsinki 44
Mexico City 43
Campinas 41
Hebei 41
London 41
Baghdad 40
Florence 40
Vienna 40
Chicago 38
Genova 38
Amsterdam 37
Poplar 36
Guayaquil 35
Lancaster 35
Bologna 34
Hangzhou 34
Manchester 34
Boston 33
Phoenix 33
Shenzhen 33
Zhengzhou 33
Düsseldorf 32
Jakarta 32
Naples 32
Ningbo 32
Norwalk 32
Brno 31
Haikou 31
Salvador 31
Totale 29.354
Salva come PNG Salva come JPEG
Nome #
La sindrome MIA ( malnutrizione-infiammazione-aterosclerosi nel paziente uremico 1.534
Amiloidosi renale e fibrosi cistica: Ruolo della terapia con colchicina 771
Terapia nutrizionale nell'IRC in fase conservativa: suggerimenti di pratica clinica e di applicazione delle linee guida 462
Henoch-Schonlein purpura associated with acetaminophen and codeine. 386
Impotence in the XVIII century as described by Gian Pietro Fusanacci and Tommaso Eduardo Beatty 291
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 252
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 241
[Management of hyperphosphatemia in patients with chronic kidney disease] 235
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 231
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 226
[From hyponatremia to tolvaptan] 225
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 225
Association of higher advanced oxidation protein  products (AOPPs) levels in patients with diabetic  and hypertensive nephropathy 223
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 222
A new approach to the evaluation of hyperphosphatemia in chronic kidney disease 221
[Renal and extra-renal involvement in sclerodermia.] 221
Association of VDR gene polymorphisms with heart disease in chronic kidney disease patients 212
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 209
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 208
Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity. 206
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 199
Sclerostin levels in uremic patients: a link between bone and vascular disease 198
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 194
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 193
Defense mechanisms in hemodialysis-dependent patients 192
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 192
Association of parathyroid carcinoma and thyroid disorders: A clinical review 191
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 191
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 188
History of L-carnitine: Implications for renal disease 185
The Myth of Water and Salt: From Aquaretics to Tenapanor 185
An update on calcium metabolism alterations and cardiovascular risk in patients with chronic kidney disease: questions, myths and facts. 184
Adaptation of the Mishel Uncertainty of Illness Scale (MUIS) for chronic patients in Italy 184
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 184
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 183
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 182
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 181
C3 glomerulopathy in cystic fibrosis: a casereport 181
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 180
ALTERAZIONI RENALI IN UN CASO DI CRIOGLOBULINEMIA MISTA DI TIPO 2 IN UN PAZIENTE AFFETTO DA LINFOMA CON CELLULE B. 178
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 178
Endothelial dysfunction in chronic renal failure. 177
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 177
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 176
Kidney disease and psoriasis: novel evidences beyond old concepts 175
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 175
Beneficial effects of oral pure caffeine on oxidative stress 175
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 174
Absorbable phosphate in medication 174
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 173
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933) 170
A prospective, multicenter, randomized, controlled study: the Correction of Metabolic Acidosis with Use of Bicarbonate in Chronic Renal Insufficiency (UBI) Study 167
Autoimmune thyroiditis and glomerulopathies 167
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 166
Case report on pathogenetic link between gluten and IgA nephropathy 166
Stress ossidativo in una popolazione di ipertesi e nefropatici: utilità del dosaggio dell’AOPP 165
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 165
Impotence in the 18th and 19th century: concepts of etiology and approaches to therapy. 164
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy 164
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 164
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 164
A longitudinal study of sleep disorders in early-stage chronic kidney disease 163
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 163
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 163
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis 161
[From scientific evidence to clinical recommendations: outlooks and challenges for the SIN (Italian Society of Nephrology)] 160
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 159
Analisi dei costi dell’eritropoietina in dialisi nella regione sicilia 158
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 158
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 158
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 157
Autonomic dysfunction in uremia 156
Kidney biopsy in type 2 diabetic patients: Critical reflections on present indications and diagnostic alternatives 156
Vascular access for hemodialysis: current perspectives 155
Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease 155
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 154
Nephro-oncology: a link in evolution 154
Dense deposit disease in a child with febrile sore throat 154
Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis 154
Copy number variant analysis and genome-wide association study identify loci with large effect for vesicoureteral reflux 154
The aggressive diabetic kidney disease in youth-onset type 2 diabetes: Pathogenetic mechanisms and potential therapies 154
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 154
EFFECTIVENESS OF L-CARNITINE THERAPY IN UREMIC ANEMIA 153
Choice of dialysis treatment and type of medical unit (private vs public): application of a recursive bivariate probit 153
Caso clinico di una bambina con lichen follicolare e sindrome nefrosica 153
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system 153
Socio-economic factors, food habits and phosphorus levels in patients on hemodialysis 153
Cystic Fibrosis: A Risk Condition for Renal Disease 152
[Nutritional diet therapy in the management of the patient with Chronic Kidney Disease in advanced phase to delay the beginning and reduce the frequency of dialysis. An option also in the pre-emptive transplant program] 152
A Delphi consensus panel on nutritional therapy in chronic kidney disease 152
Pain in Renal Disease. 151
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 151
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 151
Compliance ed emozioni in una popolazione di emodializzati 150
TERAPIA DELLE GLOMERULONEFRITI A LESIONI ISTOLOGICHE MINIME 149
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 149
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 149
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 148
Meccanismi di difesa in soggetti sottoposti a trattamento dialitico cronico 148
ACUTE PARICALCITOL ADMINISTRATION REDUCE INFLAMMATION IN CKD PATIENTS IN VIVO AND IN VITRO 148
Totale 20.137
Salva come PNG Salva come JPEG
Categoria #
all - tutte 183.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.465
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021140 0 0 0 0 0 0 0 0 0 0 0 140
2021/20223.004 56 182 123 147 109 51 203 149 128 490 402 964
2022/20236.667 558 523 309 469 508 639 103 386 2.806 75 201 90
2023/20242.053 175 288 152 146 170 368 41 129 33 204 59 288
2024/20258.846 138 61 193 465 385 349 333 1.919 2.173 563 840 1.427
2025/202626.999 1.273 1.779 2.548 2.137 2.311 5.396 3.074 3.128 3.015 1.084 694 560
Totale 54.850